Psychiatry

The Global Head of Neurodegeneration for Genentech talks about the progress of 2 promising monoclonal antibodies.

The agency warns that the seizure and bipolar disorder medication can cause hemophagocytic lymphohistiocytosis, a rare but very serious immune system reaction.

Brexanolone received breakthrough therapy designation in September 2016, underscoring the significant unmet need in women suffering from postpartum depression.

An Alzheimer’s diagnosis may cause fear, but the broad spectrum of cognitive impairment means some physicians can continue to practice despite the disease.

Current research shows that positive parenting strategies are linked with improved social-emotional development, but gaps in analysis persist.

Irritability was associated with widespread neural activation or increased activity in the insula, caudate, dorsolateral and ventrolateral prefrontal cortex, and inferior parietal lobule.

The NDA acceptance comes just days after the FDA issued a Refusal to File letter to Alkermes for its investigational MDD therapy.

Next generation sequencing technology is coming on strong in the clinical setting. The FDA would like to help it better reach the market.

Investigators noted promising results for secondary outcomes but demonstrated no difference for the primary outcome of reducing hospital visits due to self-harm.

The antipsychotic was approved by the FDA in 2016 on the backing of what researchers now consider unsubstantial clinical evidence.

The Global Burden of Disease study found that US mortality has improved since 1990 — but has been caused by worse health measures.

Global studies show the practice is still rare, but growing in countries to have legalized it.

A new assessment of the association between alcoholism and brain structure is emphasized by current data indicating a major increase of 106.7% in alcohol use disorder in the US population aged 65 years or older.

Legislators and a libertarian think-tank have flaunted the merits of the Right-to-Try experimental drug policy. But physicians question its value and the message it sends to patients.

The FDA is requesting that additional clinical trials, along with a bioavailability study, are needed to resubmit ALKS 5461.

A survey of beliefs about Alzheimer’s disease dementia identified the stigmas that pose a hurdle to clinical trials for therapies.

When a physician becomes famous, opportunities abound. How can they ensure they’re leveraging the limelight responsibly?

The placebo-controlled study found that the supplement reduced physiological as well as psychological symptoms of PMS.

Depressive mood and irritability in childhood was found to double the likelihood of suicidality in adolescence.

Analysis including 2,848,768 deaths since 1980 has revealed increases in mortality rates due to drug abuse disorders, as well as increases in rates for self-harm and alcohol use disorders since 2000.

A new study found that NAS rates have increased 433% from 2004 to 2014.

How the nation’s excessive spending and poor health outcomes drove researchers to seek solutions.

Participants taking anti-depressants 36% more likely to develop atrial fibrillation.

The survey estimates from the National Center for Health Statistics report that more people are vaccinating for flu and testing for HIV.

The physician community on Twitter is a vibrant, diverse one. But the platform's use in and out of the clinic is still subject to debate.